(Q42947924)

11 November 2017

Reply: 'Comments on Stromal disrupting effects of nab-paclitaxel in pancreatic cancer'. (English)

1 reference

11 November 2017

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24642623%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Manuel Hidalgo

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24642623%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Monica Musteanu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24642623%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Pedro P López-Casas

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24642623%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Diego Megías

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24642623%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

author name string

R Alvarez

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24642623%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

E Garcia-Garcia

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24642623%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

M Muñoz

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24642623%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Y Quijano

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24642623%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

A Cubillo

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24642623%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

J Rodriguez-Pascual

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24642623%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

C Plaza

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24642623%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

E de Vicente

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24642623%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

S Prados

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24642623%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

S Tabernero

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24642623%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

M Barbacid

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24642623%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

F Lopez-Rios

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24642623%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

language of work or name

English

0 references

publication date

18 March 2014

1 reference

British Journal of Cancer

11 November 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24642623%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

volume

111

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24642623%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24642623%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

page(s)

1677-1678

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24642623%20AND%20SRC:MED&resulttype=core&format=json

Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine

10 June 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200079

Stromal disrupting effects of nab-paclitaxel in pancreatic cancer

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200079

nab-Paclitaxel potentiates gemcitabine activity by reducing cytidine deaminase levels in a mouse model of pancreatic cancer

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200079

Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200079

Neoadjuvant chemotherapy in pancreatic cancer: innovative, but still difficult

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200079

Stellate cells, a point of light in the dark night of pancreatic cancer

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200079

16 August 2018

Identifiers

DOI

10.1038/BJC.2014.129

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24642623%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

10 June 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24642623%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

PubMed publication ID

24642623

1 reference